title: [Current therapy of non-melanoma skin cancer].
abstract: Basal cell carcinoma, actinic keratosis as a carcinoma in situ and squamous cell carcinoma are classified as non-melanoma epithelial skin cancers. These forms of skin cancer are thought to be the most common cancers worldwide with rising incidences. In the past years new insights into the pathogenesis of non-melanoma skin cancers have been gained. Through knowledge of the pathologic pathways, new treatment options have become available. This review summarizes the recent advantages of treatment options of non-melanoma skin cancer.
authors.affiliation: Klinik für Dermatologie und Venerologie, Hauttumorzentrum Köln, Uniklinik Köln. max.schlaak@uk-koeln.de
authors.forename: M
authors.initials: M
authors.lastname: Schlaak
authors.forename: W
authors.initials: W
authors.lastname: von Bartenwerffer
authors.forename: C
authors.initials: C
authors.lastname: Mauch
mesh_terms: D002280:Basal Cell Carcinoma / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D006801:Humans; D055623:Keratosis, Actinic / Q000628:therapy*; D011230:Precancerous Conditions / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*